期刊名称：PHARMACOTHERAPY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Pharmacotherapy is devoted to publication of original research articles on all aspects of human pharmacology and review articles on drugs and drug therapy. The editors and editorial board invite original research reports on pharmacokinetic, bioavailability, and drug interaction studies, clinical trials, investigations of specific pharmacological properties of drugs, and related topics.
Original reports are published in one of the following departments:
- Original Research Articles. These are full-length original research articles in such areas as therapeutics, pharmacokinetics, pharmacodynamics, and pharmacoeconomics.
- Brief Reports. These original research reports are preliminary reports of studies that have a high potential for significant impact.
- Practice Insights. These articles report innovative clinical practice or pharmacoeconomic advances, which may be centered in any practice setting such as the community, hospital, clinic, or a collaborative practice. An assessment of clinical or humanistic outcomes is required.
- Case Reports. Case reports detail interesting clinical cases that provide relevant insights into drug therapy. Authors are encouraged to include an extensive review of the literature.
Review articles may be spontaneously submitted or may be prepared at the invitation of the editor. Authors are encouraged to call and suggest possible topics. Most reviews are published in one of the following departments:
- Reviews of Therapeutics. These articles are state-of-the-art reviews on the drug treatment of specific diseases, or are comprehensive critical reviews of recently marketed drugs.
- Minireviews. These are brief, concise, and focused articles on controversies, dilemmas, and significant changes in drug therapy including important new drugs that may be in late-phase trials or have been recently marketed.
- Alternative Viewpoints. This correspondence clarifies or challenges any of our previously published articles and, whose publication, would benefit the readership in general. Submissions to this department must be received within 3 months of the publication of the article in question.
All manuscripts are subject to review by qualified consultants and the editors, and are accepted for publication if they are thought to be important contributions to the biomedical literature. The manuscript checklist (see checklist below), must accompany submitted pages. Authors are invited to call the editor to clarify any issues. The manuscript requirements of Pharmacotherapy generally conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Ann Intern Med 1982;96(1 Part 1): 766&endash;71).
The content of Pharmacotherapy is protected by copyright. Manuscripts are accepted for publication with the understanding that their contents, all or in part, have not been published elsewhere, except in abstract form, or by the express consent of the editor. Pharmacotherapy accepts no responsibility for statements made by contributors.
Advertising is accepted, subject to the editor's approval, for prescription drugs and related products used by health practitioners in patient care. Inquiries should be addressed to the advertising representative, Professional Media Group, 40 North Woodbury Road, Pitman, NJ 08071 (telephone 800-486-5454).
Requests for change of address should be sent in writing to the publisher at least 6 weeks before the change is effective. Missing issues will be replaced at no charge up to 3 months following the date of issue. A charge of $10 per missing issue will be assessed for claims received after 3 months but less than 12 months following the date of issue. Thereafter, the full back-issue price will be charged.
Secondary services that cover articles in Pharmacotherapy include Biological Abstracts, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Current Awareness in Biological Sciences, and Referativnyi Zhurnal. Pharmacotherapy is microfilmed by University Microfilms International of Ann Arbor, Michigan.
Instructions to Authors
To expedite the review and publication of manuscripts, the editors of Pharmacotherapy require that a copy of this form be completed and submitted with each paper. By completing this form authors will meet the major stylistic requirements of Pharmacotherapy. Authors must comply with and check each point on the list or mark "NA" for not applicable.
Manuscripts should be submitted to:
Richard T. Scheife, Pharm.D.
Editor-in-Chief, Pharmacotherapy
New England Medical Center/806
750 Washington Street
Boston, MA 02111
General
___ Letter of transmittal includes an explicit mailing address (no P.O. boxes), telephone and fax numbers, and e-mail address for the corresponding author.
___ Two complete copies (including figures) are submitted.
___ The complete manuscript is supplied on disk in Microsoft Word format.
___ Manuscript is typed double-spaced throughout (including tables, references, footnotes, figure legends and author identification).
___ All pages are numbered consecutively (in the upper right-hand corner), beginning with the title page and including tables.
___ Each of the following elements begins on a separate page in this sequence: title page, abstract, text, acknowledgements, references, footnotes, tables, figure legends, figures.
___ Abbreviations are in accordance with the AMA Manual of Style, 9th edition.
___ For high-impact, time-sensitive articles, expedited review is available, with sufficient justification to the Editor-in-Chief.
Title Page
___ Includes concise, informative title.
___ Includes first name, middle initial, last name and highest academic degree of each author.
___ Includes institutional affiliation section with specific department or laboratory.
___ Includes address for reprint requests.
___ Acknowledges the source(s) of support in the form of grants, equipment, or drugs. Specifically, any support from a pharmaceutical manufacturer must be acknowledged.
___ If the paper was presented, in whole or in part, at a meeting, includes name of meeting, location, and date.
___ Includes running head.
Abstract (not required for letters to the editor)
___ Concisely states objectives, methods (procedures), main results (including specific data and their statistical significance, if possible), and principal conclusions.
___ Abstracts for Original Research Articles must conform to the format outlined in Annals of Internal Medicine 1987;106:598&endash;604. A style sheet may be requested.
Text
___ First-level headings are typed as upper and lower case, bold, flush left; second-level headings are upper and lower case, flush left; third-level headings are upper and lower case, italics, flush left.
___ When reporting experiments on humans, indicates whether the procedures followed were in accord with the ethical standards of the institution's committee on human experimentation or in accord with the Helsinki Declaration of 1975.
___ When reporting experiments on animals, indicates whether institution's or the National Research Council's guide for the care and use of laboratory animals was followed.
___ Identifies precisely all drugs and chemicals by generic name. Trade names should be listed once, unless a specific trade name preparation is being discussed.
___ Measurements and units are reported in the centimeter-gram-second (CGS or metric) system.
___ For commercial products important to the paper, denotes, in parentheses, the trade name or model no.; the manufacturer's name, city, and zip code; and the lot no. If such designations are numerous, they are listed as footnotes at the end of the text.
References
___ Are cited consecutively in the order in which they appear in the paper. References cited in figure legends and tables are also numbered consecutively as they appear in the text.
___ Are identified in text, tables, and legends by superscript arabic numbers.
___ Do not include any "unpublished observations" and "personal communications" (references to written, not oral, communications may be inserted, in parentheses, in the text).
___ Have been verified by the author(s) against the original documents.
___ Abbreviations of journal titles conform to those used in Index Medicus.
___ Are in the style adopted by the U.S. National Library of Medicine and used in Index Medicus. Examples of this style follow:
- Journal article&emdash;List all authors when six or less; when seven or more, list only first three and add et al; identify abstracts and letters in parentheses at end of title.
- Miller RR. Drug surveillance utilizing epidemiologlc methods: a report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm 1973;30:584&endash;92.
- Book&emdash;personal author(s):
- Greenblatt DJ, Shader Rl. Benzodiazepines in clinical practice. New York: Raven press, 1974:28.
- Chapter in a book:
- Scheife RT, Levy M, Greenblatt DJ. Antimicrobial agents. In: Miller RR, Greenblatt DJ, eds. Drug effects in hospitalized patients. New York: John Wiley and Sons, 1976:227&endash;64.
- Package insert:
- Merck Sharp & Dohme. Prilosec (omeprazole) package insert. West Point, PA; 1991.
- Promotional literature:
- Endo Laboratories. Nubain physician's monograph. Garden City, NY; 1979 Aug.
Tables
___ Do not use "table tools" available with software programs.
___ Are in Pharmacotherapy style, with each column separated by tabs.
___ Are typed double-spaced, each (complete with title and footnotes) on a separate page (not submitted as photographs).
___ Do not contain information duplicated by figures.
___ Do not contain horizontal or vertical rules within the tabulated information.
___ Use superscript letters for footnote designations.
___ If entire table is from another published or unpublished source, permission is obtained from the source (proof submitted with paper) and the source is acknowledged.
___ References first cited in tables are numbered so that they will be in sequence with references cited in the text.
Figures (one complete original set)
___ Highest-quality figures are computer generated, submitted on disk, and saved as a high-resolution Postscript (EPS) or TIFF format. Graphics or charts may be submitted in Microsoft Excel only if the numerical value of each data point is provided to the journal. Please call for further information. Alternatively, high-quality, large-format (e.g., 8.5" x 11") laser prints may be submitted. Freehand or typewritten lettering is unacceptable.
___ Axis labels appear outside the axes.
___ Titles and detailed explanations are in the legends, not the illustrations themselves.
___ Legends are typed double-spaced on separate sheets.
___ Are numbered consecutively as they are cited in the text.
___ If previously published, the original source is acknowledged, and written permission from the copyright holder to reproduce the material is submitted.
___ Each figure is labeled with the appropriate figure number.
___ Authors are responsible for obtaining permission from the copyright holder of all figures and forwarding it to Pharmacotherapy before revised manuscripts will be accepted.
Copyright, Originality, and Liability
___ Include the following copyright transferral and acceptance of liability statements in the manuscript transmittal letter or on a separate sheet signed by each author and dated:
In consideration of the journal Pharmacotherapy taking action in reviewing and editing my (our) submission, the author(s) undersigned hereby transfer(s), assign(s), or otherwise convey(s) all ownership rights in the submission and all copyright ownership to Pharmacotherapy Publications, Inc. In the event that such work is not published in Pharmacotherapy, all said rights shall be released.
All undersigned authors agree that they are solely responsible for the opinions, judgements, and data expressed or implied in their manuscript and further agree that Pharmacotherapy does not share in that responsibility.
___ Include the following originality statement in the manuscript transmittal letter, or on a separate sheet signed by the primary or corresponding author:
I certify that none of the material in this manuscript has been previously published and none of this material is under consideration, or has been accepted for publication elsewhere. This includes journal articles, letters to the editor, symposia, proceedings, transactions, books, articles published by invitation and preliminary publications of any kind except an abstract of 400 words or less.
Editorial Board
Richard T. Scheife, Pharm.D.
Editor-in-Chief, Pharmacotherapy
New England Medical Center/806
750 Washington Street
Boston, MA 02111
|
